According to the new market research report launched by Inkwood Research, the global botanical and plant derivative drug market was valued at $37865 million in 2016 and is anticipated to reach $51881 million by 2025, growing at an estimated CAGR of 3.53%, during the forecast period 2017-2025.
Browse 25 market data Tables and 40 Figures spread through 180 Pages and in-depth analysis on “Global Botanical and plant derivative drug market by types (terepenes, steroids, glycosides, phenols and other types) by therapeutic applications (oncology, dermatology, CNS disorders, hormone diseases and other therapeutic applications) by products (herbal/ traditional topical analgesics, herbal/ traditional cough, cold and allergy (Hay Fever) remedies, herbal/ traditional digestive remedies, herbal/ traditional dermatological, herbal/traditional pediatric dietary supplements, herbal/ traditional dietary supplements and herbal/ traditional tonics) & by Geography- Regional Trends & Forecast to 2025”
This insightful market research report from Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, and Rest of World the report is a valuable asset for the existing players, new entrants, and the future investors. The study presents detailed market analysis with inputs derived from industry professionals across the value chain.
Botanical and plant derivative drug market scenario
Growing application in diseases, increase in the FDA approvals, technological development in manufacturing processes, rising demand for traditional medicines and growing focus towards natural source medicines are the reasons for the growth of the global botanical and plant derivative drug market.
The Botanical and plant derivative drug Market report provides data tables, includes charts and graphs for visual analysis.
Market Segmentation
On the basis of type, the Global Botanical and plant derivative drug market is segmented as follows:
- Terpenes
- Steroids
- Glycosides
- Phenols
- Other types
On the basis of therapeutic applications, the Global Botanical and plant derivative drug market is segmented as follows:
- Oncology
- Dermatology
- CNS disorders
- Hormone diseases
- Other therapeutic applications
On the basis of market therapies, the Global Botanical and plant derivative drug market is segmented as follows:
- Herbal/ traditional topical analgesics
- Herbal/ traditional cough, cold and allergy (Hay Fever) remedies
- Herbal/ traditional digestive remedies
- Herbal/ traditional dermatological
- Herbal/ traditional pediatric dietary supplements
- Herbal/ traditional dietary supplements
- Herbal/ traditional tonics
Get Sample Copy of Report @ https://www.inkwoodresearch.com/reports/global-botanical-and-plant-derivative-drug-market-forecast-2017-2025/#request-free-sample
Report Highlights
- The report provides a detailed analysis of current and future market trends to identify the investment opportunities
- Market forecasts till 2025, using estimated market values as the base numbers
- Key market trends across the business segments, regions and countries
- Key developments and strategies observed in the market
- Market dynamics such as drivers, restraints, opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2025
- Market opportunities and recommendations for new investments
- The report provides a detailed analysis of current and future market trends to identify the investment opportunities
- Market forecasts till 2025, using estimated market values as the base numbers
- Key market trends across the business segments, regions and countries
- Key developments and strategies observed in the market
- Market dynamics such as drivers, restraints, opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2025
- Market opportunities and recommendations for new investments
Companies Profiled
- Abbot Laboratories
- Bayer Healthcare
- Bionova
- Bristol- Myers Squibb
- Cura Pharm
- ELI Lilly And Company
- Glaxosmithkline
- Glenmark Pharmaceuticals LTD.
- Lupin LTD
- Medigene
- Novartis International AG
- Pfizer
- Pirmaal Phytocare LTD.
- Ranbaxy Laboratories LTD (Acquired by SUN Pharmaceuticals LTD)
- Tasly Pharmaceuticals INC.
Related Reports
- GLOBAL CANNABIS TESTING MARKET FORECAST 2017-2025
- GLOBAL CENTRAL NERVOUS SYSTEM MARKET FORECAST 2017-2025
- GLOBAL ANTI-DEPRESSANT DRUGS, DEVICES, AND THERAPIES MARKET FORECAST 2017-2025
- GLOBAL OPIOID INDUCED CONSTIPATION DRUG MARKET FORECAST 2017-2025
Contact Us:
Inkwood Research
169, Harrison Avenue
Boston, MA 02111
Tel: +1 857-302-4704
Website: www.inkwoodresearch.com
Comments
Post a Comment